Rasmussen H S, Kehlet H
Ugeskr Laeger. 1989 Aug 28;151(35):2184-6.
The literature is reviewed with the aim of comparing the effect of resuscitation with colloid solutions with that of crystalloid solutions in the following patient categories: patients undergoing major elective abdominal surgery, patients in hypovolemic shock due to acute trauma and patients in septic shock. None of the clinical trials have documented that resuscitation with colloids is superior to that of crystalloids alone as regards mortality or frequency of complications. On the contrary, colloid resuscitation appears to be detrimental in patients with traumainduced hypovolemic shock with a higher incidence of pulmonary and cardiac complications as compared to resuscitation with crystalloids alone. This is contrary to what is expected from the Starling equation and the discrepancy between the theoretical and clinical findings is discussed. Furthermore, resuscitation with colloids is about 50 times more expensive than resuscitation with crystalloids. On the basis of the clinical data and the higher cost of colloids, the authors recommend cessation of the use of colloids in the abovementioned conditions.
接受大型择期腹部手术的患者、因急性创伤导致低血容量性休克的患者以及感染性休克患者。没有一项临床试验记录表明,在死亡率或并发症发生率方面,胶体溶液复苏优于单纯晶体溶液复苏。相反,与单纯晶体溶液复苏相比,胶体溶液复苏似乎对创伤性低血容量性休克患者有害,会导致更高的肺部和心脏并发症发生率。这与根据斯塔林方程的预期结果相反,本文讨论了理论与临床研究结果之间的差异。此外,胶体溶液复苏的成本比晶体溶液复苏贵约50倍。基于临床数据和胶体溶液的较高成本,作者建议在上述情况下停止使用胶体溶液。